1-3 of 3
Conrad Russell Cruz
Close
Sort by
Journal Articles

Broad Spectrum Tumor Antigen-Specific Cytotoxic T Lymphocytes (CTL) for Therapy of Hematological Malignancy.

Ulrike Gerdemann, MD, Anne S. Christin, MD, Conrad Russell Cruz, MD, Carlos A. Ramos, MD, Donald R. Shaffer, Stephen Gottschalk, MD, Helen E. Heslop, MD, Malcolm K. Brenner, MB, PhD, FRCP, FRCPath, Catherine M. Bollard, MD, FRACP, FRCPA, Cliona M. Rooney, PhD, Ann M. Leen, PhD
Journal: Blood
Blood (2009) 114 (22): 4083.
https://doi.org/10.1182/blood.V114.22.4083.4083
Published: 2009
Journal Articles

Cytotoxic T Lymphocytes (CTL) Specific for Adenovirus and CMV Can Be Generated from Umbilical Cord Blood for Adoptive Immunotherapy

Catherine M. Bollard, MD, Patrick Hanley, Conrad Russell Cruz, Ann M. Leen, PhD, Jeffrey J. Molldrem, MD, Hao Liu, PhD, Adrian P. Gee, PhD, Helen E. Heslop, MD, Gianpietro Dotti, MD, Barbara Savoldo, MD, Elizabeth J. Shpall, MD
Journal: Blood
Blood (2008) 112 (11): 3505.
https://doi.org/10.1182/blood.V112.11.3505.3505
Published: 2008
Journal Articles

The “Side-Population” of Human Lymphoma Cells Have Increased Chemo-Resistance, Stem-Cell Like Properties and Are Potential Targets for Immunotherapy

Jessica Ann Shafer, M.D., Ann M. Leen, PhD, Conrad Russell Cruz, John A Craddock, M.D., Helen E. Heslop, M.D., Cliona M. Rooney, PhD, Malcolm K Brenner, MD, PhD, Catherine M. Bollard, MD, FRACP, FRCPA, Aaron Foster, PhD
Journal: Blood
Blood (2008) 112 (11): 2620.
https://doi.org/10.1182/blood.V112.11.2620.2620
Published: 2008